South African-based Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories.
Aspen is represented in South Africa, Australia, Hong Kong, Malaysia, Philippines, Taiwan, Japan, Kenya, Nigeria, Tanzania, Uganda, Ireland, United Arab Emirates, France, Germany, the Netherlands, Mauritius, Brazil, Mexico, Venezuela and the United States of America. Acquisitions announced in 2013 have further extended the Group’s emerging market presence to the Commonwealth of Independent States, comprising Russia and the former Soviet Republics as well as to Central and Eastern Europe. The Group currently has 50 business units.
The Group has 26 manufacturing facilities at 18 sites on 6 continents and approximately 8200 employees.
Aspen is listed on the JSE Ltd and is included in its Top 40 Index.
Aspen is a leading generics manufacturer in the Southern hemisphere and is Africa’s largest pharmaceutical manufacturer.
Aspen is South Africa’s leading pharmaceutical company in the private sector (IMS).
Aspen is ranked as the ninth largest generic company in the world (EvaluatePharma World Preview – June 2013).
Nearly one in four prescriptions dispensed by pharmacists in South Africa continues to be for an Aspen product.
Aspen has production capabilities for a wide variety of product types including tablets, capsules, eye drops, injectable products (including lyophilized vials), oral contraceptives, form-filled seals, suppositories, liquids, creams, ointments, infant nutritional products, and specialist active pharmaceutical ingredients.
Aspen has an outstanding generic pipeline. These products are developed under the direction of highly skilled scientists employed by Aspen and in collaboration with other global pharmaceutical companies and research facilities.
Aspen products are renowned for their quality, efficacy and affordability.
Please enter your email address
Please enter a valid email address